Rheumatoid Arthritis Recruiting Phase Trials for Adalimumab (DB00051)

Also known as: Rheumatoid Arthritis(RA) / Rheumatoid Arthritis, NOS / Rheumatoid Arthritis RA / Rhematoid Arthritis / Rheumatic Arthritis / Rheumatoid Arthritis (RA) / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Arthritis, Rheumatoid (RA) / Rheumatoid Arthritis(RA) / RA / Systemic rheumatoid arthritis / Rheumatoid arthritis (disorder) / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Rheumatoid arthritis NOS / Rheumatoid arthritis NOS (disorder)

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03662919One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study
NCT01197144Pain Modulation in Rheumatoid Arthritis (RA) - Influence of AdalimumabBasic Science
NCT04449224Comparative Effectiveness of Targeted Therapy in RA Patients
NCT01965132Korean College of Rheumatology Biologics Registry
NCT02620189Th17 Responses Evaluated in RA Patients on Inhibitors of TNFα
NCT04089514A Real-world Study of Imraldi® Use